Kiran Musunuru of the Perelman School of Medicine says that a new infusion offers the hope of precisely treating other genetic diseases by fixing mutations, an alternative to current gene therapies.
Every Cure, a nonprofit founded by David Fajgenbaum of the Perelman School of Medicine, has received $108 million in federal contracts and private financing to identify promising disease-medication matches and make recommendations for further clinical study.
Image: iStock/TanyaJoy
Sherry Gao, Tyler Daniel (pictured), and their coauthors have developed a new tool that can simultaneously and independently edit multiple genes and regulate their expression.
(Image: Bella Ciervo)
A black squirrel on College Green in the fall of 2024.
nocred
Image: iStock/baona
A paper co-authored by PIK Professor Shelley Berger finds that patterns of “speckles” in the heart of tumor cells could help predict how patients with a common form of kidney cancer will respond to treatment options.
Scientists at Penn are trying to develop a template for groups of rare conditions that are similar enough to be affected by a single, easily adaptable gene-editing treatment.
David Fajgenbaum of the Perelman School of Medicine helped found Every Cure, a biotechnology nonprofit that employs AI to help match existing treatments to new diseases.
Image: iStock/Alllex